Skip to content

Evaluation of aromatherapy in palliative care

Evaluation of aromatherapy in palliative care - EVA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00017411
Enrollment
60
Registered
2019-05-28
Start date
2019-06-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R45.1

Interventions

Group 1: Lavender oil, from which 3 drops are applied to a swab <1 meter distance to the patient for 30 minutes Group 2: Melissa oil, from which 3 drops are applied to a swab <1 meter distance to the

Sponsors

Interdisziplinäre Schmerz- und Palliativstation Klinik für Anästhesiologie und Operative Intensivmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: a) give their consent, b) have a sense of smelling, c) are in a single room.

Exclusion criteria

Exclusion criteria: a) no consent, b) allergies to the fragrances or essential oils, c) no smelling ability (tracheal cannula, runny nose, etc.), d) no life-limiting illness, or e) other (foreign language, no caregiver etc.).

Design outcomes

Primary

MeasureTime frame
Change in the Richmond Agitation Sedation Scale, assessed 5 minutes before and 15, 30, and 60 minutes after the intervention

Secondary

MeasureTime frame
Minimal documentation system (MIDOS2), a self-constructed scale "confidence" (0-10, 10 = maximum confidence) and vital signs (heart and respiratory rate, blood pressure), assessed 5 minutes before and 60 minutes after the intervention. Other parameters are the feasibility of the intervention (degree of recruitment, ratio of performed vs. indicated interventions, Number of safety events), assessed during the study period.

Countries

Germany

Contacts

Public ContactKai Rossen

Interdisziplinäre Schmerz- und Palliativstation Klinik für Anästhesiologie und Operative Intensivmedizin

Kai.Rossen@UKSH.de0431/ 500 20920

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026